Streetbeat News

Price Targets

ALXO

Cantor Fitzgerald analyst Alethia Young has reinstated ALX Oncology Holdings (NASDAQ:ALXO) with an Overweight rating and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:31 pm

AFMD

Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on Affimed (NASDAQ:AFMD) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:30 pm

DOCU

Citigroup analyst Tyler Radke maintains a Buy rating on DocuSign (NASDAQ:DOCU) and raises the price target from $78 to $81.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:29 pm

TW

Citigroup analyst Christopher Allen maintains a Buy rating on Tradeweb Markets (NASDAQ:TW) and raises the price target from $92 to $100.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:27 pm

MU

Citigroup analyst Christopher Danely maintains a 'Buy' rating on Micron Technology (NASDAQ:MU) and raises the price target from $75 to $85.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:25 pm

AEO

Citigroup analyst Paul Lejuez has maintained a Neutral rating on American Eagle Outfitters (NYSE:AEO) and raised the price target from $17 to $18.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:23 pm

PHR

Citigroup analyst Daniel Grosslight maintains a Buy rating on Phreesia (NYSE:PHR) but lowers the price target from $40 to $37.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:15 pm

PSNY

Polestar Automotive's stock has been downgraded by Barclays from Equal-Weight to Underweight, with the price target also being reduced from $5 to $3. This has resulted in the shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:08 pm

PODD

UBS has cut the price target for Insulet from $270 to $215, causing the company's shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:04 pm

AVAV

AeroVironment (NASDAQ:AVAV) has received various analyst ratings in the last quarter, with 1 bullish, 3 somewhat bullish, and 1 indifferent. The average 12-month price target for the company, according to 5 analysts, is $114.6, an increase of 9.14% from the previous average of $105.00.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm